April 2024
Federal Court says Blumenthal market rigging was ‘serious, deliberate’
The stockbroker will be banned from managing companies for five years and pay an $850,000 penalty four months after reaching an agreement with the regulator.
- Jonathan Shapiro and Liam Walsh
January 2024
ASIC got Adam Blumenthal for market rigging. Why didn’t it go harder?
Regulators had launched raids in 2021 into trading with a Sydney stockbroker and an influencer. A confession was extracted, only on a civil penalty basis.
- Liam Walsh and Jonathan Shapiro
December 2023
ASIC, Blumenthal strike settlement two years after raids
The stockbroker has agreed to a five-year ban but gets to keep his business, after the regulator’s probes into market rigging.
- Liam Walsh, Jemima Whyte and Jonathan Shapiro
August 2023
Inside Adam Blumenthal’s burgeoning property portfolio
If all goes to plan, he’ll make millions flipping luxury properties in Sydney’s leafiest locales. At least, that’s the plan.
- Myriam Robin
March 2023
We’re not as bad as iSignthis, says Creso Pharma
It’s Boaz Wachtel’s lot to lead Creso and Australian markets as a whole through a notable milestone.
- Myriam Robin
December 2022
- Updated
- Shares
Finfluencers on notice as ‘ASX Wolf’ breaches licence laws
Lamborghini-driving share trader Tyson Scholz has been found to have broken rules relating to financial advice in a landmark win for the corporate regulator.
- Liam Walsh and Aleks Vickovich
James Ellingford keeps his other EverBlu job
The former Creso Pharma chairman has resigned with $144,000 to be paid out over 12 months.
- Michael Roddan
November 2022
Creso Pharma’s TikTok star charged with stalking
Despite the charges, the listed marijuana company is awarding Dr James Ellingford an $80,000 bonus.
- Michael Roddan
Pot stock Creso Pharma chairman exits after wild TikTok spectacle
The medicinal cannabis company has a lot on its microwaved-warmed plate at the moment.
- Michael Roddan
October 2022
Creso Pharma chairman’s unmissable TikTok show
It’s admittedly less than high times at listed pot stock Creso Pharma.
- Michael Roddan
Creso breached ‘related party’ disclosure rules
An entity controlled by the parents of stockbroker and former Creso director Adam Blumenthal will dispose of shares after the company says listing rules were breached.
- Liam Walsh, Jemima Whyte and Jonathan Shapiro
Inside the raid that undid ASX Wolf
Pandemic handouts and a booming sharemarket spawned a new social media stock frenzy. But who has been the real winner?
- Updated
- Liam Walsh, Jonathan Shapiro and Jemima Whyte
Secrets of ASIC raids on EverBlu, ASX Wolf revealed
Court documents reveal what the corporate regulator was looking for when it raided a Sydney stockbroker and a flashy Gold Coast sharetrader last November.
- Liam Walsh, Jonathan Shapiro and Jemima Whyte
August 2022
Adam Blumenthal keeps his distance from Creso
There’s barely a cigarette paper between the EverBlu chairman and the ASX pot stock.
- Michael Roddan
February 2022
ASX Wolf: ‘I’ve been just getting on with business and with trading’
ASIC’s case against share trader Tyson Scholz claims the ‘ASX Wolf’ reaped $1.16 million in 10 months from selling ‘stockmarket courses’, court documents allege.
- Liam Walsh, Jemima Whyte and Jonathan Shapiro
December 2021
Inside the ASX Wolf’s $1K members-only share pit
Traders are turning to new social media platforms to get an edge, and willing to pay big dollars for access.
- Liam Walsh
John Hancock’s stock picks turn money into headlines
By his own telling, Gina Rinehart’s estranged son has in recent years been after something ‘a little more exciting’. With Creso, Vulcan and Magnis, he’s struck gold.
- Myriam Robin
November 2021
Creso promotes Dr Ellingford
His other ASX directorships in recent years include Pursuit Minerals, MinRex Resources, Hardey Resources and Victory Minds. All are Everblu clients.
- Myriam Robin
Wolf raid: the 36-year-old ASX trader who ‘made $1m in 28 weeks’
Tyson Scholz has attracted 22,300 followers with his flashy social-media lifestyle and sharetrading. But amid an ASIC probe, he says he’s done nothing wrong.
- Updated
- Liam Walsh, Jemima Whyte and Jonathan Shapiro
EverBlu’s Blumenthal steps down at Creso over ASIC trading probe
After a two-day trading halt, Creso Pharma says it is caught up in an ASIC investigation because of its links to EverBlu Capital.
- Updated
- Jemima Whyte and Liam Walsh